Serina Therapeutics Shares Drop 6.25% as Market Capitalization Stays at $41.9M
Serina Therapeutics shares fell 6.25% to $1.65, 22.9% down YTD, amid a 200‑day average of $2.11. Explore its cell‑immortality biotech focus and market trend.
- SERINA THERAPEUTICS INC.
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read